Lotus Ventures Inc.
CA$0.01CA$0.00 (0.0%)
Lotus Ventures Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
TSXV · NHP.V · CAD
Stock price
Quote as of Dec 8, 2022, 02:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Lumiera Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Lumiera Health Inc., along with its affiliated entities, specializes in developing and marketing botanical products, backed by scientific evidence, for the Canadian healthcare sector. The company provides both orally administered and topically applied botanical remedies designed to address unmet medical needs, particularly in the areas of sleep support and pain management. Its product portfolio features the Holizen brand, which includes a range of herbal tonics and dietary supplements aimed at enhancing cardiovascular health, reducing stress, improving bone, joint, and muscle mobility, and boosting energy and immunity. Additionally, Lumiera offers sleep assistance solutions under its Bazzzics brand and a specific pain relief cream through the Awaye brand. The principal operations of Lumiera Health Inc. are located in Saint-Hubert, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:39 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CA$0.01CA$0.00 (0.0%)
Lotus Ventures Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
CA$0.01-CA$0.01 (-50.0%)
NeutriSci International Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.01CA$0.00 (0.0%)
Gnomestar Craft Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.06CA$0.00 (0.0%)
Green Scientific Labs Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Indigenous Bloom Hemp Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Aequus Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.25% below the high.
$0.00$0.00 (0.0%)
MPX International Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Avivagen Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.67% below the high.